Lipoprotein(a): The Hidden Genetic Heart Risk You Need to Know

You have your diet under control. You hit the gym regularly. Your standard cholesterol numbers look decent. Yet, somewhere in your blood, a silent genetic timer might be ticking toward a heart attack or stroke. This isn't about bad habits; it's about Lipoprotein(a), often abbreviated as Lp(a). It is a specific type of particle that carries cholesterol through your bloodstream, but unlike regular LDL (the "bad" cholesterol), you cannot lower it by eating better or running more miles. In fact, your levels are determined almost entirely by your DNA.

For decades, doctors ignored this marker because there was nothing they could do about it. That is changing fast. With new treatments on the horizon and updated guidelines calling for universal screening, understanding Lp(a) has moved from a niche academic interest to a critical part of preventive heart care. If you have a family history of early heart disease, or if you’ve been told your cholesterol is hard to manage, this hidden factor could be the missing piece of the puzzle.

What Exactly Is Lipoprotein(a)?

To understand why Lp(a) is dangerous, you first need to know what it is. Think of standard LDL cholesterol as a delivery truck carrying cargo (cholesterol) to your arteries. Now, imagine that truck has a sticky, velcro-like strap attached to its side. That strap is apolipoprotein(a). This unique structure makes Lp(a) particles stickier and more likely to lodge themselves in your artery walls compared to regular LDL.

This particle was first identified in 1963 by Swedish researcher Kare Berg, but it took decades to recognize its threat. Today, we know that Lp(a) does two harmful things simultaneously. First, like LDL, it delivers cholesterol to form plaques in your arteries. Second, and this is where it gets tricky, its unique structure interferes with your body’s ability to break down blood clots. It mimics a protein called plasminogen, which normally helps dissolve clots. By blocking this process, Lp(a) promotes clot growth. So, you get plaque buildup AND higher clotting risk-a double whammy for your cardiovascular system.

The Genetic Lottery: Why Your Levels Are Fixed

Here is the frustrating part about Lp(a): you didn’t choose these levels, and you can’t easily change them. Research shows that 70% to 90% of Lp(a) variation is genetically determined. Specifically, variations in the LPA gene control how much apolipoprotein(a) your liver produces. Dr. Tsimikas, a leading expert cited by the National Heart, Lung, and Blood Institute, calls it "likely the leading inherited risk for cardiovascular disease." It is more heritable than hypertension, diabetes, or obesity.

If one of your parents has high Lp(a), you have a 50% chance of inheriting it. This is an autosomal dominant trait. However, just because you inherit the gene doesn't mean you are doomed. As Dr. Tsimikas notes, "Even if the level is elevated, it doesn't mean you are going to have an event. It just puts you at a higher risk." The key is knowing your status so you can aggressively manage other risk factors.

Who Should Get Tested? The Screening Gap

Despite affecting roughly one in five people worldwide, Lp(a) remains underdiagnosed. Why? Because it is not included in a standard lipid panel. When you go for a routine check-up, the lab measures total cholesterol, HDL, LDL, and triglycerides. Lp(a) is absent unless your doctor specifically orders it. This creates a dangerous blind spot in millions of patients' health records.

Current guidelines from organizations like the American Heart Association and the European Society of Cardiology recommend measuring Lp(a) at least once in a lifetime for adults. However, testing is especially urgent if you fall into these categories:

• You have a personal or family history of premature heart disease (heart attack or stroke before age 55 in men or 65 in women).
• You have been diagnosed with familial hypercholesterolemia (FH), a condition causing very high LDL.
• You have calcification of the aortic valve.
• You belong to a demographic with statistically higher risks, such as Black individuals, who consistently show higher Lp(a) levels than White, Hispanic, or Asian populations.

Dr. Gregory Schwartz, a cardiologist at the University of Colorado, advocates for universal screening. He argues that since Lp(a) is a common genetic risk factor, everyone should know their number to tailor their prevention strategy effectively.

Understanding Your Results: What Do the Numbers Mean?

When you finally get tested, you might see results in different units, which can be confusing. Labs may report Lp(a) in mg/dL or nmol/L. Here is how to interpret them:

Note that conversion between units isn't always perfect due to lack of standardization across labs, but generally, anything above 50 mg/dL (or 105 nmol/L) signals increased cardiovascular risk. Levels above 125 nmol/L equate to a significantly higher chance of heart attack or stroke. If your result is high, don't panic, but do take action.

Why Lifestyle Changes Don't Lower Lp(a)

This is the most counterintuitive part for patients. You can eat kale every day, run marathons, and quit smoking, and your Lp(a) levels will likely stay exactly the same. Unlike LDL, which responds dramatically to diet and exercise, Lp(a) is stubbornly resistant to lifestyle modifications. Some studies suggest minor fluctuations with extreme dietary changes or hormone shifts, but for practical purposes, consider your baseline level fixed.

Does this mean lifestyle doesn't matter? Absolutely not. While you can't lower Lp(a) directly, you must aggressively lower your *other* risks. Since Lp(a) adds to your overall danger profile, reducing LDL, controlling blood pressure, and avoiding smoking become even more critical. Think of it this way: if you have a headwind (high Lp(a)), you need to make sure your engine (your heart health) is in peak condition to compensate.

Current Treatment Options and Limitations

Historically, doctors had few tools to fight high Lp(a). Standard statins, the gold standard for lowering LDL, have little to no effect on Lp(a) and may even slightly raise it in some cases. Niacin (vitamin B3) can lower Lp(a) by 20-30%, but clinical trials have failed to prove that this reduction actually prevents heart attacks, and the side effects (flushing, liver stress) often outweigh the benefits.

Bile acid sequestrants and PCSK9 inhibitors (like evolocumab) can modestly lower Lp(a) by about 20-25%. These are sometimes used if a patient also needs significant LDL lowering, but they are not strong enough to neutralize the risk of very high Lp(a) levels on their own.

The Future: Promising New Therapies

The landscape is shifting rapidly. For the first time, we have drugs designed specifically to silence the production of Lp(a). These are known as antisense oligonucleotides (ASOs). One leading candidate, pelacarsen (formerly TQJ230), has shown remarkable results in Phase 2 trials, reducing Lp(a) levels by up to 80%.

The industry is now waiting for the results of the Phase 3 Lp(a) HORIZON Outcomes Trial. This massive study is evaluating whether lowering Lp(a) with pelacarsen actually reduces cardiovascular events in high-risk patients. Results are expected around 2025-2026. If successful, this could revolutionize heart care, moving us from merely managing symptoms to targeting the root genetic cause.

In the meantime, another class of drugs, siRNAs (small interfering RNAs) like olpasiran, is also in advanced trials. These work similarly to ASOs but may offer longer-lasting effects with less frequent dosing. The consensus among experts is that targeted therapy is coming, and soon.

Action Plan: What To Do Next

If you suspect you might have high Lp(a), here is your step-by-step plan:

1. Ask for the Test: At your next appointment, ask your doctor, "Can we check my Lp(a) levels?" Specify that you want it measured in nmol/L if possible, as this unit is becoming the international standard for consistency.
2. Know Your Family History: Gather information about heart attacks, strokes, or valve issues in your parents, siblings, and grandparents. Note the ages at which these occurred.
3. Aggressively Manage LDL: If your Lp(a) is high, your target LDL should be lower than average. Aim for LDL below 70 mg/dL, or even lower if you have existing heart disease.
4. Screen for Valve Issues: High Lp(a) is linked to aortic stenosis (hardening of the heart valve). If you have a heart murmur or unexplained shortness of breath, request an echocardiogram.
5. Stay Updated: Follow reputable sources like the American Heart Association or National Heart, Lung, and Blood Institute for updates on new therapies like pelacarsen.

Frequently Asked Questions